{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:53:46Z","timestamp":1753883626105,"version":"3.41.2"},"reference-count":23,"publisher":"The Endocrine Society","issue":"2","license":[{"start":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T00:00:00Z","timestamp":1573603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Children with congenital adrenal hyperplasia (CAH) because of 21 hydroxylase deficiency (21OHD) are at risk for early or precocious puberty and a short adult height compared to population means and midparental height. The effect of histrelin in suppressing puberty and improving growth in these children has not been reported.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Retrospective cohort analysis of all patients (age \u2264 20) at our institution who underwent histrelin implantation between 2008 and 2017. Treated patients with CAH (classic and nonclassic forms of 21OHD) were identified and their growth data analyzed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Fifteen children with CAH were treated with histrelin for a median of 3 years (range 2\u20135; age at first implantation 7.7 \u00b1 1.5 years). Bone age (BA) to chronologic age (CA) decreased from 1.57 \u00b1 0.4 to 1.25 \u00b1 0.25 (P &amp;lt; .01), while predicted adult height (PAH) increased by 7.1 \u00b1 6.6 cm (P &amp;lt; .01). A subgroup of 10 children reached adult height. Similar changes in BA\/CA and PAH were observed with therapy (P = .02). Adult height z improved compared to pretreatment PAH z (\u20131.42 \u00b1 0.9 vs. \u20131.96 \u00b1 1.1 respectively, P &amp;lt; .01), but remained lower than midparental height z (P = .01).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>In this retrospective cohort study of children with CAH due to 21OHD and early or precocious puberty, histrelin implantation resulted in a decrease in BA progression compared to CA and an improvement in PAH. In the subgroup who completed growth, adult height remained significantly lower than midparental. These results need to be confirmed with prospective controlled studies.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jendso\/bvz004","type":"journal-article","created":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T21:32:12Z","timestamp":1573680732000},"source":"Crossref","is-referenced-by-count":0,"title":["Histrelin Implantation and Growth Outcomes in Children With Congenital Adrenal Hyperplasia: An Institutional Experience"],"prefix":"10.1210","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1592-0120","authenticated-orcid":false,"given":"Robert A","family":"Swendiman","sequence":"first","affiliation":[{"name":"Department of Surgery, University of Pennsylvania, Philadelphia, PA, US"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1810-9533","authenticated-orcid":false,"given":"Barbara E","family":"Coons","sequence":"first","affiliation":[{"name":"Department of Surgery, Columbia University, New York, NY, US"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig A","family":"Alter","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Diabetes, Children\u2019s Hospital of Philadelphia, Philadelphia, PA, US"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaneeta","family":"Bamba","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Diabetes, Children\u2019s Hospital of Philadelphia, Philadelphia, PA, US"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael L","family":"Nance","sequence":"first","affiliation":[{"name":"Division of General, Thoracic, and Fetal Surgery, Children\u2019s Hospital of Philadelphia, Philadelphia, PA, US"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1941-8277","authenticated-orcid":false,"given":"Maria G","family":"Vogiatzi","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Diabetes, Children\u2019s Hospital of Philadelphia, Philadelphia, PA, US"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2019,11,13]]},"reference":[{"issue":"3","key":"2020022121393408600_CIT0001","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/MED.0b013e328346938c","article-title":"Congenital adrenal hyperplasia: an update in children","volume":"18","author":"Trapp","year":"2011","journal-title":"Curr Opin Endocrinol Diabetes Obes."},{"issue":"11","key":"2020022121393408600_CIT0002","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2020022121393408600_CIT0003","doi-asserted-by":"crossref","first-page":"5680","DOI":"10.1210\/jc.2003-030123","article-title":"CYP21 genotype, adult height, and pubertal development in 55 patients treated for 21-hydroxylase deficiency","volume":"88","author":"Balsamo","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2020022121393408600_CIT0004","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1210\/jc.2009-0942","article-title":"Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence-based recommendation","volume":"94","author":"Bonfig","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"2020022121393408600_CIT0005","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1210\/jc.2009-2616","article-title":"Clinical review: adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis","volume":"95","author":"Muthusamy","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2020022121393408600_CIT0006","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1210\/js.2019-00036","article-title":"Treatment of central precocious puberty","volume":"3","author":"Eugster","year":"2019","journal-title":"J Endocr Soc."},{"issue":"5","key":"2020022121393408600_CIT0007","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1210\/jcem-58-5-857","article-title":"True precocious puberty complicating congenital adrenal hyperplasia: treatment with a luteinizing hormone-releasing hormone analog","volume":"58","author":"Pescovitz","year":"1984","journal-title":"J Clin Endocrinol Metab."},{"key":"2020022121393408600_CIT0008","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1749-6632.1993.tb43873.x","article-title":"Congenital adrenal hyperplasia complicated by central precocious puberty: treatment with LHRH-agonist analogue","volume":"687","author":"Dacou-Voutetakis","year":"1993","journal-title":"Ann N Y Acad Sci."},{"issue":"5","key":"2020022121393408600_CIT0009","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0026-0495(97)90186-4","article-title":"Congenital adrenal hyperplasia complicated by central precocious puberty: linear growth during infancy and treatment with gonadotropin-releasing hormone analog","volume":"46","author":"Soliman","year":"1997","journal-title":"Metabolism."},{"issue":"2","key":"2020022121393408600_CIT0010","first-page":"265","article-title":"Gonadotropin releasing hormone analog treatment in children with congenital adrenal hyperplasia complicated by central precocious puberty","volume":"14","author":"G\u00fcven","year":"2015","journal-title":"Hormones (Athens)."},{"issue":"7","key":"2020022121393408600_CIT0011","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1515\/jpem-2015-0406","article-title":"Near-final height in 82 Chinese patients with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency: a single-center study from China","volume":"29","author":"Juan","year":"2016","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"4","key":"2020022121393408600_CIT0012","first-page":"1511","article-title":"Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia","volume":"86","author":"Quintos","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2020022121393408600_CIT0013","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1210\/jc.2010-2699","article-title":"Final adult height in children with congenital adrenal hyperplasia treated with growth hormone","volume":"96","author":"Lin-Su","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2020022121393408600_CIT0014","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1210\/jc.2006-2479","article-title":"Efficacy and safety of histrelin subdermal implant in children with central precocious puberty: a multicenter trial","volume":"92","author":"Eugster","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"2020022121393408600_CIT0015","article-title":"Histrelin implantation in the pediatric population: a 10-year institutional experience","author":"Swendiman","year":"2018","journal-title":"J Pediatr Surg"},{"issue":"1","key":"2020022121393408600_CIT0016","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-3476(95)70255-5","article-title":"Spontaneous serum gonadotropin concentrations in the evaluation of precocious puberty","volume":"127","author":"Neely","year":"1995","journal-title":"J Pediatr."},{"issue":"239","key":"2020022121393408600_CIT0017","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/adc.45.239.13","article-title":"Variations in the pattern of pubertal changes in boys","volume":"45","author":"Marshall","year":"1970","journal-title":"Arch Dis Child."},{"key":"2020022121393408600_CIT0018","volume-title":"Radiographic Atlas of Skeletal Development of the Hand and Wrist","author":"Greulich","year":"1959","edition":"2"},{"issue":"6","key":"2020022121393408600_CIT0019","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1210\/jc.2014-3031","article-title":"Long-term continuous suppression with once-yearly histrelin subcutaneous implants for the treatment of central precocious puberty: a final report of a phase 3 multicenter trial","volume":"100","author":"Silverman","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020022121393408600_CIT0020","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000185432","article-title":"Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue: a comparative study with re-evaluation of predictions by the Bayley-Pinneau method","volume":"47","author":"Kauli","year":"1997","journal-title":"Horm Res."},{"issue":"9","key":"2020022121393408600_CIT0021","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1210\/jcem.86.9.7852","article-title":"Sexual precocity in boys: accelerated versus slowly progressive puberty gonadotropin-suppressive therapy and final height","volume":"86","author":"Lazar","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2020022121393408600_CIT0022","doi-asserted-by":"crossref","first-page":"133","DOI":"10.14740\/jocmr3710","article-title":"The gonadotropin-releasing hormone analogue therapy may not impact final height in precocious puberty of girls with onset of puberty aged 6\u20138 years","volume":"11","author":"Korkmaz","year":"2019","journal-title":"J Clin Med Res."},{"issue":"7-8","key":"2020022121393408600_CIT0023","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1515\/jpem-2012-0122","article-title":"Overestimation of final height prediction in patients with classical congenital adrenal hyperplasia using the Bayley and Pinneau method","volume":"25","author":"Bonfig","year":"2012","journal-title":"J Pediatr Endocrinol Metab."}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvz004\/30700697\/bvz004.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jes\/article-pdf\/4\/2\/bvz004\/32540827\/bvz004.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jes\/article-pdf\/4\/2\/bvz004\/32540827\/bvz004.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,22]],"date-time":"2020-02-22T02:40:13Z","timestamp":1582339213000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvz004\/5625146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,13]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvz004","relation":{},"ISSN":["2472-1972"],"issn-type":[{"type":"electronic","value":"2472-1972"}],"subject":[],"published-other":{"date-parts":[[2020,2]]},"published":{"date-parts":[[2019,11,13]]},"article-number":"bvz004"}}